Indies Pharma Jamaica Limited (JMSE: INDIES)

Market Cap	4.53B
Revenue (ttm)	1.14B
Net Income (ttm)	215.57M
Shares Out	1.33B
EPS (ttm)	0.16
PE Ratio	21.25
Forward PE	n/a
Dividend	0.11 (3.20%)
Ex-Dividend Date	Jul 15, 2024

Volume	82,723
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	2.250 - 3.440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2024

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. It offers prescription and over the counter drugs in tablet, topical creams, ointment, suspension, injection, capsule, sachet and dispersible tablet, oral mixture, cream, solution, gel, shampoo, drop, chewable tablet, syrup, nasal spray, vaginal cream and pessary, tonic, and oral powder and solution dosage forms. The company provides its products for use as cardiovascular agents, including anti-hypertensive, circulation and ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 71
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In 2023, Indies Pharma Jamaica's revenue was 1.06 billion, an increase of 12.61% compared to the previous year's 937.28 million. Earnings were 213.06 million, a decrease of -3.50%.